A Case of Immune Checkpoint Inhibitor-Induced Probable Myocarditis and Treatment Response

Immune checkpoint inhibitors (ICI) are a new class of pharmaceuticals that facilitate the immune system in identifying and targeting cancerous cells. However, suppressing immune regulation can often cause immune-mediated adverse events. One such downstream effect recently recognized is ICI-associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Mubariz A, Batta, Yashvardhan, Afzal, Muhammad Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310539/
https://www.ncbi.nlm.nih.gov/pubmed/37398769
http://dx.doi.org/10.7759/cureus.39692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310539/
https://www.ncbi.nlm.nih.gov/pubmed/37398769
http://dx.doi.org/10.7759/cureus.39692

Ejemplares similares